AViTA Corporation - Asset Resilience Ratio
AViTA Corporation (4735) has an Asset Resilience Ratio of 12.22% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 4735 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how AViTA Corporation's Asset Resilience Ratio has changed over time. See how leveraged is AViTA Corporation's balance sheet to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down AViTA Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see AViTA Corporation market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$165.55 Million | 12.22% |
| Total Liquid Assets | NT$165.55 Million | 12.22% |
Asset Resilience Insights
- Moderate Liquidity: AViTA Corporation has 12.22% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
AViTA Corporation Industry Peers by Asset Resilience Ratio
Compare AViTA Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for AViTA Corporation (2017–2025)
The table below shows the annual Asset Resilience Ratio data for AViTA Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 12.22% | NT$165.55 Million ≈ $5.22 Million |
NT$1.35 Billion ≈ $42.68 Million |
+4.50pp |
| 2024-12-31 | 7.72% | NT$92.00 Million ≈ $2.90 Million |
NT$1.19 Billion ≈ $37.52 Million |
-1.65pp |
| 2023-12-31 | 9.38% | NT$116.17 Million ≈ $3.66 Million |
NT$1.24 Billion ≈ $39.04 Million |
+4.97pp |
| 2022-12-31 | 4.40% | NT$58.91 Million ≈ $1.86 Million |
NT$1.34 Billion ≈ $42.15 Million |
+0.13pp |
| 2021-12-31 | 4.28% | NT$72.50 Million ≈ $2.28 Million |
NT$1.69 Billion ≈ $53.40 Million |
+1.91pp |
| 2020-12-31 | 2.37% | NT$60.00 Million ≈ $1.89 Million |
NT$2.53 Billion ≈ $79.80 Million |
+0.58pp |
| 2019-12-31 | 1.79% | NT$18.66 Million ≈ $587.86K |
NT$1.04 Billion ≈ $32.80 Million |
+0.64pp |
| 2018-12-31 | 1.15% | NT$12.44 Million ≈ $391.93K |
NT$1.08 Billion ≈ $33.99 Million |
-1.76pp |
| 2017-12-31 | 2.91% | NT$28.62 Million ≈ $901.56K |
NT$982.28 Million ≈ $30.95 Million |
-- |
About AViTA Corporation
AViTA Corporation engages in the research, development, manufacturing, and sales of home healthcare products. Its products include non-contact thermometer, infrared ear/forehead thermometer, infrared ear thermometer, wrist type blood pressure monitor, arm type blood pressure monitor, nasal aspirator, nebulizer, electronic breast pump, pulse oximeter, and electronic lice comb. AViTA Corporation wa… Read more